ZEB2 and non-small cell lung carcinoma: In conclusion, our findings highlight a previously unrecognized role of the transcription factor ZEB2 in supporting lung tumor-reactive Teff cell differentiation and the anti-tumor efficacy of CD8+ TILs in NSCLC.